Clinical Roundup Small molecule inhibitor blocks prostate cancer bone metastasis April 03, 2026Vol.52 No.13
Clinical Roundup Talzenna + Xtandi significantly improves radiographic PFS in metastatic prostate cancer March 27, 2026Vol.52 No.12
Clinical Roundup Researchers “turbocharge” immune cells to attack prostate cancer March 27, 2026Vol.52 No.12
Clinical Roundup Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, UCLA-led study finds March 06, 2026Vol.52 No.09
Clinical Roundup Adjuvant immunotherapy + hormone therapy may counteract immune-suppression in early-stage prostate cancer, Mayo-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup Androgen receptor alterations in bloodwork linked to poorer outcomes across therapies treating metastatic prostate cancer February 27, 2026Vol.52 No.08
Clinical Roundup Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds February 13, 2026Vol.52 No.06
Clinical Roundup Oxybutynin reduces hot flashes during prostate cancer treatment, randomized study finds February 06, 2026Vol.52 No.05
Clinical Roundup UCLA launches trial comparing two types of PSMA radiopharmaceuticals for recurrent prostate cancer January 30, 2026Vol.52 No.04
Sponsored Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community January 23, 2026Vol.52 No.03By Tanya Dorff
